Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases
- PMID: 36074655
- PMCID: PMC10034699
- DOI: 10.1177/19714009221126015
Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases
Abstract
2016 World Health Organization (WHO) Classification of Tumors of the Central Nervous System (CNS) has shown how molecular features can impact the classification of brain tumors. The continued combination of molecular features with histopathology has led to distinguish tumors with similar histopathologic features but distinct clinical prognosis. The 2021 revised 5. edition of the WHO classification further includes molecular features for CNS tumor categorization including MYB/MYBL1 altered diffuse astrocytoma which is a newly recognized type of low-grade pediatric-type brain tumor. We discuss imaging features of two pediatric-type low-grade gliomas with MYB/MYBL1-mutation that encountered at our institution.
Keywords: MYB; MYBL1; glioma; imaging; pediatric; radiology.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures


References
-
- Ellison DW, Hawkins C, Jones DTW, et al. cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation. Acta Neuropathol (Berl) 2019; 137(4): 683–687. - PubMed
-
- Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol (Berl) 2016; 131(6): 803–820. - PubMed
-
- Johnson DR, Kaufmann TJ, Patel SH, et al. There is an exception to every rule—T2-FLAIR mismatch sign in gliomas. Neuroradiology 2019; 61(2): 225–227. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources